Latest MorphoSys Stories
Heptares to Moderate Panel on Global Business Development at Upcoming Boston Biotech East/West CEO Conference
WELWYN GARDEN CITY, England and BOSTON, January 8, 2014 /PRNewswire/ -- Heptares Therapeutics, the leading GPCR drug discovery and development company, notes that its President,
Word of the Day
- Large; stout; burly.
The word 'bowerly' is an alteration of 'burly'.